PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study

• Yigal M Pinto,
• Matthias Pauschinger,
• Finn Gustafsson,
• FD Richard Hobbs,
• Hector Bueno,
• Michael Obermeier,
• Benoit Lequeux,
• Rizwan I Hussain,
• Cristina Vitale,
• Philippe C Ferber

Affiliations

Yigal M Pinto

Departments of Cardiology and Experimental Cardiology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands

Matthias Pauschinger

Department of Cardiology, General Hospital Nuremberg, Nuremburg, Germany

Finn Gustafsson

Department of Cardiology, Rigshospitalet University of Copenhagen, Copenhagen, Denmark

FD Richard Hobbs

University of Oxford, Oxford, UK

Hector Bueno

Department of Cardiology, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain

Michael Obermeier

GKM Gesellschaft für Therapieforschung mbH, Munchen, Germany

Benoit Lequeux

Poitiers University Hospital, Poitiers, France

Rizwan I Hussain

Arxx Therapeutics, Oslo, Norway

Cristina Vitale

Department of Medical Sciences, IRCCS San Raffaele Pisana, Roma, Italy

Philippe C Ferber

Novartis Pharma AG, Basel, Switzerland